Advent Life Sciences Promotes Kaasim Mahmood to General Partner and Alain Huriez to Partner

Press Release:


London, UK. November 10 2014



Advent Life Sciences today announced the promotion of Kaasim Mahmood, MD to General Partner. Kaasim has been with Advent since 2005 and has been responsible for several investments including uniQure, CN Creative and NeRRe Therapeutics.

Alain Huriez, MD is promoted to Partner. Alain, based in Paris France, joined Advent in 2012 as a Venture Partner.

About Advent Life Sciences.
Advent Life Sciences is one of Europe's leading venture teams investing in life sciences businesses. The team consists of 11 professionals with extensive scientific, medical and operational experience, and a long-standing track record of entrepreneurial and investment success across the UK, Europe and the US. The Firm invests in a range of sectors within life sciences, principally in new drug discovery, enabling technologies, and med tech. Realisations in the last three years include Algeta, Avila, CN Creative, EUSA, Micromet. Current investments include Acutus, Biocartis, Cellnovo, F2G, NeRRe, Versartis. For more information, please visit www.adventLS.com



Contact : Advent Life Sciences
Raj Parekh, General Partner
Phone : +44(0)207 932 2100
email : Raj.Parekh@adventLS.com

Back